Tag: NEJM study
-
System-Level Intervention Reduces Maternal Infections and Deaths
Overview Maternal infections and sepsis remain a leading concern in obstetric care, contributing to significant morbidity and, in some cases, mortality. A recent study published in the New England Journal of Medicine demonstrates that a comprehensive, system-level, multifactorial intervention can substantially reduce the risk of maternal infection outcomes. The findings suggest that coordinated changes across…
-
System-level Intervention Slashes Maternal Infections and Deaths, New NEJM Study Finds
Overview: A Multifactorial Approach to Maternal Health Maternal infections and sepsis remain critical contributors to pregnancy-related morbidity and mortality worldwide. A new study published in the New England Journal of Medicine (NEJM) highlights a system-level, multifactorial intervention that substantially reduced the risk of maternal infection outcomes. The research underscores how coordinated changes across clinical care,…
-
System-Level Intervention Cuts Maternal Infections and Deaths, NEJM Study Finds
New Evidence from a Landmark Study A comprehensive study published in the New England Journal of Medicine shows that a system-level, multifactorial intervention significantly reduced maternal infection outcomes and related mortality. The findings suggest that tackling maternal health risks requires coordinated changes across clinical practice, hospital infrastructure, and community care, rather than isolated efforts by…
-
System-Level Intervention Reduces Maternal Infections and Deaths
Breakthrough shows how multifactorial care can save lives A recent study published in the New England Journal of Medicine highlights a significant decline in maternal infections and related deaths following the implementation of a comprehensive, system-level intervention. The research points to a multifactorial strategy that integrates clinical practices, health system reforms, and coordinated patient care…
-
Age Impacts Systemic Therapy in Metastatic Prostate Cancer
New evidence links age to systemic therapy outcomes in metastatic prostate cancer When oncologists assemble a treatment plan for metastatic prostate cancer, they weigh many factors—from tumor genetics to patient comorbidities. A provocative addition to this list is chronological age. A study published in the October 28, 2025 edition of the New England Journal of…
-
Experimental gene therapy restores immune system function in ADA-SCID children
Groundbreaking therapy offers durable immune restoration for ADA-SCID An experimental gene therapy developed by researchers at UCLA, University College London (UCL) and Great Ormond Street Hospital (GOSH) has achieved durable restoration of immune system function in 59 of 62 children born with ADA-SCID, a rare and often deadly genetic immune disorder. The long-term follow-up results,…
-
Long-term success for gene therapy in children with ADA-SCID: a landmark study
Groundbreaking long-term results for ADA-SCID gene therapy A multinational team led by Great Ormond Street Hospital (GOSH), University College London (UCL), and the University of California, Los Angeles (UCLA) has reported the longest follow-up to date for children treated with a gene therapy for ADA-SCID, a rare immune deficiency. The study, published in the New…